Combined obeticholic acid and apoptosis inhibitor treatment alleviates liver fibrosis

por Zhou, Jiyu, Huang, Ningning, Guo, Yitong, Cui, Shuang, Ge, Chaoliang, He, Qingxian, Pan, Xiaojie, Wang, Guangji, Wang, Hong, Hao, Haiping
Publicado 2019

SUMOylation inhibitors synergize with FXR agonists in combating liver fibrosis

por Zhou, Jiyu, Cui, Shuang, He, Qingxian, Guo, Yitong, Pan, Xiaojie, Zhang, Pengfei, Huang, Ningning, Ge, Chaoliang, Wang, Guangji, Gonzalez, Frank J., Wang, Hong, Hao, Haiping
Publicado 2020

Noncanonical farnesoid X receptor signaling inhibits apoptosis and impedes liver fibrosis

por Wang, Hong, Ge, Chaoliang, Zhou, Jiyu, Guo, Yitong, Cui, Shuang, Huang, Ningning, Yan, Tingting, Cao, Lijuan, Che, Yuan, Zheng, Qiuling, Zheng, Xiao, Gonzalez, Frank J., Wang, Guangji, Hao, Haiping
Publicado 2018